| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Cellular Physiology and Biochemistry |
2025―Jul―29 |
Post-Acute COVID-19 Pathophysiology: Cellular Stress Responses, Immune Dysregulation, and Biochemical Signatures in Recovery Phase |
|
| 2 |
[GO] |
Cellular Physiology and Biochemistry |
2025―Apr―05 |
Enhancing Cellular Immunity Through Epitope Peptides of SARS-CoV-2 in Individuals with Specific HLA Allele |
|
| 3 |
[GO] |
Cellular Physiology and Biochemistry |
2023―Feb―01 |
Magnesium (Mg2+) Deficiency, Not Well-Recognized Non-Infectious Pandemic: Origin and Consequence of Chronic Inflammatory and Oxidative Stress-Associated Diseases |
|
| 4 |
[GO] |
Cellular Physiology and Biochemistry |
2022―Dec―20 |
Possible Therapeutic Targets from Derivatives of Natural Marine Products Based on PI3K/AKT Dependent Inhibitors in Viral Infection COVID-19 |
Aleebrahim-Dehkordi Elahe |
| 5 |
[GO] |
Cellular Physiology and Biochemistry |
2022―Nov―25 |
Simvastatin Therapy Increased miR-150-5p Expression in the Patients with Type 2 Diabetes and COVID-19 |
|
| 6 |
[GO] |
Cellular Physiology and Biochemistry |
2022―Jun―07 |
Supporting Cells of the Human Olfactory Epithelium Co-Express the Lipid Scramblase TMEM16F and ACE2 and May Cause Smell Loss by SARS-CoV-2 Spike-Induced Syncytia |
|
| 7 |
[GO] |
Cellular Physiology and Biochemistry |
2020―Aug―25 |
Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2 |
|